Literature DB >> 12071818

The mechanical properties of skin in osteogenesis imperfecta.

Birgitte Hansen1, Gregor B E Jemec.   

Abstract

BACKGROUND: Skin mechanics may be affected by several dermatological and systemic conditions. The skin can act as a marker of generalized disease. Osteogenesis imperfecta (OI) is a heritable disorder characterized by fragile bones caused by a generalized disorder of collagen. The dermis has a relative increase of argyrophil and elastic fibers and a deficiency of adult collagen. The collagen defect is well described, but functional changes in tissue mechanics have not been studied in the skin. The functional changes may reflect general changes and may give insight into the pathogenesis of clinical problems in these patients.
OBJECTIVE: To examine skin mechanics (elasticity, distensibility, and hysteresis) in patients with OI.
METHODS: Ten patients with OI (mean +/- SD age, 45.9 +/- 11.5 years) and 24 age-matched control subjects (mean +/- SD age, 43.3 +/- 13.8 years) were studied. The suction cup technique was used (Dermaflex; Cortex Technology, Hadsund, Denmark).
RESULTS: Significant differences between the patients and controls were found in all measurements (P<.002). Skin elasticity was decreased in patients vs controls (55.5% [range, 50.9%-60.1%] vs 73.8% [range, 70.3%-77.2%]). Similarly, distensibility was decreased (2.10 mm [range, 1.85-2.35 mm] vs 2.50 mm [range, 2.37-2.63 mm]), as was hysteresis (0.19 mm [range, 0.15-0.23 mm] vs 0.28 mm [range, 0.27-0.30 mm]).
CONCLUSIONS: The skin of patients with OI is more stiff and less elastic than normal skin. It is speculated that similar differences may be found in other tissues in patients with OI. The results potentially offer a quantitative standardized measure of OI, which may further our understanding of the underlying physical problems of these patients, provide better case definitions, and assist in predicting the prognosis of patients with OI.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12071818     DOI: 10.1001/archderm.138.7.909

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  11 in total

Review 1.  Advances in the Classification and Treatment of Osteogenesis Imperfecta.

Authors:  Inas H Thomas; Linda A DiMeglio
Journal:  Curr Osteoporos Rep       Date:  2016-02       Impact factor: 5.096

2.  Characterization of skin abnormalities in a mouse model of osteogenesis imperfecta using high resolution magnetic resonance imaging and Fourier transform infrared imaging spectroscopy.

Authors:  H C Canuto; K W Fishbein; A Huang; S B Doty; R A Herbert; J Peckham; N Pleshko; R G Spencer
Journal:  NMR Biomed       Date:  2011-08-15       Impact factor: 4.044

3.  Differential response to intracellular stress in the skin from osteogenesis imperfecta Brtl mice with lethal and non lethal phenotype: a proteomic approach.

Authors:  Laura Bianchi; Assunta Gagliardi; Roberta Gioia; Roberta Besio; Chiara Tani; Claudia Landi; Maria Cipriano; Anna Gimigliano; Antonio Rossi; Joan C Marini; Antonella Forlino; Luca Bini
Journal:  J Proteomics       Date:  2012-02-18       Impact factor: 4.044

4.  Generalized connective tissue disease in Crtap-/- mouse.

Authors:  Dustin Baldridge; Jennifer Lennington; MaryAnn Weis; Erica P Homan; Ming-Ming Jiang; Elda Munivez; Douglas R Keene; William R Hogue; Shawna Pyott; Peter H Byers; Deborah Krakow; Daniel H Cohn; David R Eyre; Brendan Lee; Roy Morello
Journal:  PLoS One       Date:  2010-05-11       Impact factor: 3.240

5.  Multiparametric Classification of Skin from Osteogenesis Imperfecta Patients and Controls by Quantitative Magnetic Resonance Microimaging.

Authors:  Beth G Ashinsky; Kenneth W Fishbein; Erin M Carter; Ping-Chang Lin; Nancy Pleshko; Cathleen L Raggio; Richard G Spencer
Journal:  PLoS One       Date:  2016-07-14       Impact factor: 3.240

6.  Cytoskeleton and nuclear lamina affection in recessive osteogenesis imperfecta: A functional proteomics perspective.

Authors:  Assunta Gagliardi; Roberta Besio; Chiara Carnemolla; Claudia Landi; Alessandro Armini; Mona Aglan; Ghada Otaify; Samia A Temtamy; Antonella Forlino; Luca Bini; Laura Bianchi
Journal:  J Proteomics       Date:  2017-08-09       Impact factor: 4.044

7.  Effects of incorporation of granule-lyophilised platelet-rich fibrin into polyvinyl alcohol hydrogel on wound healing.

Authors:  Fangfang Xu; Dehui Zou; Taiqiang Dai; HaiYan Xu; Ran An; Yanpu Liu; Bin Liu
Journal:  Sci Rep       Date:  2018-09-19       Impact factor: 4.379

8.  Incorporating the patient perspective in the study of rare bone disease: insights from the osteogenesis imperfecta community.

Authors:  T Swezey; B B Reeve; T S Hart; M K Floor; C M Dollar; A P Gillies; L L Tosi
Journal:  Osteoporos Int       Date:  2018-09-06       Impact factor: 4.507

9.  Assessing disease experience across the life span for individuals with osteogenesis imperfecta: challenges and opportunities for patient-reported outcomes (PROs) measurement: a pilot study.

Authors:  Laura L Tosi; Marianne K Floor; Christina M Dollar; Austin P Gillies; Tracy S Hart; David D Cuthbertson; V Reid Sutton; Jeffrey P Krischer
Journal:  Orphanet J Rare Dis       Date:  2019-01-29       Impact factor: 4.123

10.  The Stimulating Effect of Rosmarinic Acid and Extracts from Rosemary and Lemon Balm on Collagen Type I Biosynthesis in Osteogenesis Imperfecta Type I Skin Fibroblasts.

Authors:  Joanna Sutkowska; Natalia Hupert; Katarzyna Gawron; Jakub W Strawa; Michał Tomczyk; Antonella Forlino; Anna Galicka
Journal:  Pharmaceutics       Date:  2021-06-23       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.